Castellum Announces Closing of $2.7 Million Registered Direct Offering
January 29, 2024 16:30 ET
|
Castellum, Inc.
Castellum, Inc. (the “Company”) (NYSE-American: CTM) closes on registered direct offering, consisting of the sale of 8,437,501 shares.
Castellum Announces Pricing of $2.7 Million Registered Direct Offering
January 25, 2024 08:55 ET
|
Castellum, Inc.
Castellum, Inc. (the “Company”) (NYSE-American: CTM) has entered into a securities purchase agreement with an institutional investor to purchase 8,437,501
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC
June 14, 2023 09:15 ET
|
Atossa Therapeutics, Inc.
SEATTLE, June 14, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant...
Palisade Bio (Nasdaq: PALI) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group and Hosted by M-Vest
March 24, 2022 08:30 ET
|
Palisade Bio, Inc.
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...
BioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 15, 2021 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, announces...
ZIVO Bioscience to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 11, 2021 12:25 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., March 11, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic and...
Alimera Sciences to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 11, 2021 08:00 ET
|
Alimera Sciences, Inc.
ATLANTA, March 11, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription...
Immune Therapeutics, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
June 15, 2016 14:46 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., June 15, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and...